Table 6.
EL (pg/mL) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Unadjusted | Model 1 | Model 2 | Model 3 | Model 4 | ||||||
Variable | r | p | r | p | r | p | r | p | r | p |
LDL1-C/LDL1-apoB | −0.25 | 0.045 | −0.21 | 0.105 | −0.16 | 0.213 | −0.24 | 0.063 | −0.25 | 0.051 |
LDL4-FC/LDL4-apoB | 0.25 | 0.049 | 0.18 | 0.187 | 0.18 | 0.183 | 0.25 | 0.054 | 0.27 | 0.041 |
LDL4-TG/LDL4-apoB | 0.28 | 0.030 | 0.24 | 0.076 | 0.20 | 0.163 | 0.26 | 0.050 | 0.27 | 0.035 |
LDL1-PL/LDL1-apoB | −0.27 | 0.027 | −0.18 | 0.161 | −0.16 | 0.225 | −0.28 | 0.026 | −0.25 | 0.053 |
Spearman’s correlation analysis was used to evaluate associations of the serum levels of EL with the ratios indicating lipid content of IDL particles. Model 1: adjusted for age, sex, BMI, and IL-6. Model 2: adjusted for age, sex, BMI, and CRP. Model 3: adjusted for age, sex, and statin. Model 4: adjusted for age, sex, and hypertension. p-values < 0.05 are considered statistically significant and are depicted in bold. ApoB, apolipoprotein B; C, cholesterol; EL, endothelial lipase; FC, free cholesterol; HV, healthy volunteer; LDL, low-density lipoprotein; mL, milliliter; MS, metabolic syndrome patient; N, number; pg, picogram; PL, phospholipid; r, Spearman’s correlation coefficient; TG, triglyceride.